Related references
Note: Only part of the references are listed.Effects of Acute Colchicine Administration Prior to Percutaneous Coronary Intervention COLCHICINE-PCI Randomized Trial
Binita Shah et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2020)
The Role of Colchicine in Acute Coronary Syndromes
Kaivan Vaidya et al.
CLINICAL THERAPEUTICS (2019)
The Low Dose Colchicine after Myocardial Infarction (LoDoCo-MI) study: A pilot randomized placebo controlled trial of colchicine following acute myocardial infarction
Thomas Hennessy et al.
AMERICAN HEART JOURNAL (2019)
Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
Jean-Claude Tardif et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
The effect of low-dose colchicine in patients with stable coronary artery disease: The LoDoCo2 trial rationale, design, and baseline characteristics
Stefan M. Nidorf et al.
AMERICAN HEART JOURNAL (2019)
Low-Dose Methotrexate for the Prevention of Atherosclerotic Events
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Isolating Colchicine in 19th Century: An Old Drug Revisited
Marianna Karamanou et al.
CURRENT PHARMACEUTICAL DESIGN (2018)
Colchicine Therapy and Plaque Stabilization in Patients With Acute Coronary Syndrome A CT Coronary Angiography Study
Kaivan Vaidya et al.
JACC-CARDIOVASCULAR IMAGING (2018)
Anti-inflammatory therapy with canakinumab for atherosclerotic disease: lessons from the CANTOS trial
Peter L. Thompson et al.
JOURNAL OF THORACIC DISEASE (2018)
Research Progress on the Relationship between Atherosclerosis and Inflammation
Yuhua Zhu et al.
BIOMOLECULES (2018)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
COLIN trial: Value of colchicine in the treatment of patients with acute myocardial infarction and inflammatory response
Mariama Akodad et al.
ARCHIVES OF CARDIOVASCULAR DISEASES (2017)
Effects of colchicine on risk of cardiovascular events and mortality among patients with gout: a cohort study using electronic medical records linked with Medicare claims
Daniel H. Solomon et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction A Randomized Clinical Trial
Michelle L. O'Donoghue et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Colchicine in cardiac disease: a systematic review and meta-analysis of randomized controlled trials
Subodh Verma et al.
BMC CARDIOVASCULAR DISORDERS (2015)
Anti-Inflammatory Treatment With Colchicine in Acute Myocardial Infarction A Pilot Study
Spyridon Deftereos et al.
CIRCULATION (2015)
Colchicine Acutely Suppresses Local Cardiac Production of Inflammatory Cytokines in Patients With an Acute Coronary Syndrome
Gonzalo J. Martinez et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2015)
Effect of Darapladib on Major Coronary Events After an Acute Coronary Syndrome The SOLID-TIMI 52 Randomized Clinical Trial
Michelle L. O'Donoghue et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Varespladib and Cardiovascular Events in Patients With an Acute Coronary Syndrome The VISTA-16 Randomized Clinical Trial
Stephen J. Nicholls et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease
Harvey D. White et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
2013 ESC guidelines on the management of stable coronary artery disease
Gilles Montalescot et al.
EUROPEAN HEART JOURNAL (2013)
NLRP3 Inflammasomes Show High Expression in Aorta of Patients with Atherosclerosis
Fei Zheng et al.
HEART LUNG AND CIRCULATION (2013)
Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease
Stefan M. Nidorf et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Colchicine and the Heart Pushing the Envelope
Spyridon Deftereos et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Colchicine Treatment for the Prevention of Bare-Metal Stent Restenosis in Diabetic Patients
Spyridon Deftereos et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Effects of the P-Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention for Non-ST-Segment Elevation Myocardial Infarction Results of the SELECT-ACS Trial
Jean-Claude Tardif et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Long-Term Cardiovascular Risk of Nonsteroidal Anti-Inflammatory Drug Use According to Time Passed After First-Time Myocardial Infarction A Nationwide Cohort Study
Anne-Marie Schjerning Olsen et al.
CIRCULATION (2012)
Inflammation in Coronary Artery Disease and Acute Myocardial Infarction - is the Stage Set for Novel Therapies?
Roland Klingenberg et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Colchicine Use Is Associated with Decreased Prevalence of Myocardial Infarction in Patients with Gout
Daria B. Crittenden et al.
JOURNAL OF RHEUMATOLOGY (2012)
Effect of colchicine compared with placebo on high sensitivity C-reactive protein in patients with acute coronary syndrome or acute stroke: a pilot randomized controlled trial
Nina C. Raju et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2012)
Cardiogenic shock and heart failure post-percutaneous coronary intervention in ST-elevation myocardial infarction: Observations from Assessment of Pexelizumab in Acute Myocardial Infarction
John K. French et al.
AMERICAN HEART JOURNAL (2011)
Inflammasome Activation of Cardiac Fibroblasts Is Essential for Myocardial Ischemia/Reperfusion Injury
Masanori Kawaguchi et al.
CIRCULATION (2011)
Vulnerable Plaque and Inflammation: Potential Clinical Strategies
Maria Drakopoulou et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
Inflammation in Atherosclerosis From Pathophysiology to Practice
Peter Libby et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Colchicine Update: 2008
Robert A. Terkeltaub
SEMINARS IN ARTHRITIS AND RHEUMATISM (2009)
Anti-mitotic activity of colchicine and the structural basis for its interaction with tubulin
Bhabatarak Bhattacharyya et al.
MEDICINAL RESEARCH REVIEWS (2008)
Effect of colchicine (0.5 mg twice daily) on high-sensitivity C-reactive protein independent of aspirin and atorvastatin in patients with stable coronary artery disease
Mark Nidorf et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Gout-associated uric acid crystals activate the NALP3 inflammasome
F Martinon et al.
NATURE (2006)
Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease
SE Nissen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
C-reactive protein levels and outcomes after statin therapy
PM Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction - The COMplement inhibition in myocardial infarction treated with angioplasty (COMMA) trial
CB Granger et al.
CIRCULATION (2003)
Meta-analysis of corticosteroid treatment in acute myocardial infarction
GR Giugliano et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
Share Paper
